131 related articles for article (PubMed ID: 9721707)
1. Computerized nuclear morphometry of hepatocellular carcinoma and its relation to proliferative activity.
Ikeguchi M; Sato N; Hirooka Y; Kaibara N
J Surg Oncol; 1998 Aug; 68(4):225-30. PubMed ID: 9721707
[TBL] [Abstract][Full Text] [Related]
2. Computerized nuclear morphometry: a new morphologic assessment for advanced gastric adenocarcinoma.
Ikeguchi M; Oka S; Saito H; Kondo A; Tsujitani S; Maeta M; Kaibara N
Ann Surg; 1999 Jan; 229(1):55-61. PubMed ID: 9923800
[TBL] [Abstract][Full Text] [Related]
3. Computerized nuclear morphometry is a useful technique for evaluating the high metastatic potential of colorectal adenocarcinoma.
Ikeguchi M; Sakatani T; Endo K; Makino M; Kaibara N
Cancer; 1999 Nov; 86(10):1944-51. PubMed ID: 10570417
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathologic features and prognosis of resected hepatocellular carcinomas of varied sizes with special reference to proliferating cell nuclear antigen.
Suehiro T; Matsumata T; Itasaka H; Yamamoto K; Kawahara N; Sugimachi K
Cancer; 1995 Aug; 76(3):399-405. PubMed ID: 8625120
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of proliferating cell nuclear antigen expression in hepatocellular carcinoma.
Ng IO; Lai EC; Fan ST; Ng M; Chan AS; So MK
Cancer; 1994 May; 73(9):2268-74. PubMed ID: 7513246
[TBL] [Abstract][Full Text] [Related]
6. Nuclear accumulation of p53 protein in gastric cancer strongly correlates with enlargement of nuclear area of cancer cells.
Ikeguchi M; Oka S; Saito H; Kondo A; Tsujitani S; Maeta M; Kaibara N
Oncol Rep; 2000; 7(3):579-84. PubMed ID: 10767371
[TBL] [Abstract][Full Text] [Related]
7. Angiogenesis in hepatocellular carcinoma as evaluated by alpha smooth muscle actin immunohistochemistry.
Morinaga S; Imada T; Shimizu A; Akaike M; Sugimasa Y; Takemiya S; Takanashi Y
Hepatogastroenterology; 2001; 48(37):224-8. PubMed ID: 11268971
[TBL] [Abstract][Full Text] [Related]
8. Nuclear profiles of cancer cells reveal the metastatic potential of gastric cancer.
Ikeguchi M; Cai J; Oka S; Gomyou Y; Tsujitani S; Maeta M; Kaibara N
J Pathol; 2000 Sep; 192(1):19-25. PubMed ID: 10951395
[TBL] [Abstract][Full Text] [Related]
9. Relationship between loss of heterozygosity at microsatellite loci and computerized nuclear morphometry in hepatocellular carcinoma.
Suzuki K; Hirooka Y; Tsujitani S; Yamane Y; Ikeguchi M; Kaibara N
Anticancer Res; 2000; 20(2B):1257-62. PubMed ID: 10810431
[TBL] [Abstract][Full Text] [Related]
10. Proliferating cell nuclear antigen in hepatocellular carcinoma and small cell liver dysplasia.
Adachi E; Hashimoto H; Tsuneyoshi M
Cancer; 1993 Nov; 72(10):2902-9. PubMed ID: 8106139
[TBL] [Abstract][Full Text] [Related]
11. [Expression and prognostic value of proliferating cell nuclear antigen in hepatocellular carcinoma patients received preoperative transcatheter arterial chemoembolization].
Guo RP; Yu WS; Wei W
Ai Zheng; 2008 Feb; 27(2):201-5. PubMed ID: 18279622
[TBL] [Abstract][Full Text] [Related]
12. The assessment of proliferating cell nuclear antigen immunohistochemical staining in small hepatocellular carcinoma and its relationship to histologic characteristics and prognosis.
Kitamoto M; Nakanishi T; Kira S; Kawaguchi M; Nakashio R; Suemori S; Kajiyama G; Asahara T; Dohi K
Cancer; 1993 Sep; 72(6):1859-65. PubMed ID: 8103417
[TBL] [Abstract][Full Text] [Related]
13. Expression of p57(KIP2) in hepatocellular carcinoma: relationship between tumor differentiation and patient survival.
Nakai S; Masaki T; Shiratori Y; Ohgi T; Morishita A; Kurokohchi K; Watanabe S; Kuriyama S
Int J Oncol; 2002 Apr; 20(4):769-75. PubMed ID: 11894123
[TBL] [Abstract][Full Text] [Related]
14. The clinical utility of the proliferating cell nuclear antigen expression in patients with hepatocellular carcinoma.
Ma S; Yang J; Li J; Song J
Tumour Biol; 2016 Jun; 37(6):7405-12. PubMed ID: 26676639
[TBL] [Abstract][Full Text] [Related]
15. Ki-67 antigen expression in hepatocellular carcinoma using monoclonal antibody MIB1. A comparison with proliferating cell nuclear antigen.
Ng IO; Na J; Lai EC; Fan ST; Ng M
Am J Clin Pathol; 1995 Sep; 104(3):313-8. PubMed ID: 7545866
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of combination study of apoptotic factors and proliferating cell nuclear antigen in estimating the prognosis of hepatocellular carcinoma.
Osada S; Saji S; Kuno T
J Surg Oncol; 2004 Jan; 85(1):48-54. PubMed ID: 14696087
[TBL] [Abstract][Full Text] [Related]
17. Proliferating cell nuclear antigen and Ki-67 labeling in hepatocellular nodules: a comparative study.
Tiniakos DG; Brunt EM
Liver; 1999 Feb; 19(1):58-68. PubMed ID: 9928768
[TBL] [Abstract][Full Text] [Related]
18. P21/WAF1 is an independent survival prognostic factor for patients with hepatocellular carcinoma after resection.
Kao JT; Chuah SK; Huang CC; Chen CL; Wang CC; Hung CH; Chen CH; Wang JH; Lu SN; Lee CM; Changchien CS; Hu TH
Liver Int; 2007 Aug; 27(6):772-81. PubMed ID: 17617120
[TBL] [Abstract][Full Text] [Related]
19. [Relationship between the proliferative activity of cancer cells and microvessel density in portal vein thrombosis and transfer of hepatocellular carcinoma].
Meng CC; Chen XP; Liu AZ
Zhonghua Gan Zang Bing Za Zhi; 2002 Oct; 10(5):366-9. PubMed ID: 12392620
[TBL] [Abstract][Full Text] [Related]
20. Needle biopsy of hepatocellular carcinoma: assessment of prognostic contribution of histologic parameters including proliferating cell nuclear antigen labeling and correlations with clinical outcomes. Group d'Etude et de Traitement du Carcinoma Hépatocellulaire.
Chapel F; Guettier C; Chastang C; Rached AA; Mathieu D; Tepper M; Beaugrand M; Trinchet JC
Cancer; 1996 Mar; 77(5):864-71. PubMed ID: 8608476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
